Market Currents

• Thursday, October 15, 2009

• 07:55 AM Baxter (BAX): Q3 EPS of $0.98 beats by $0.01. Revenue of $3.15B (-0.2%) in-line. Shares -1% premarket. (PR) Comment!
• 00:05 AM Notable pre-market earnings: APH, BAX, SCHW, C, CY, FCS, GS, HOG, LUV, MNI, NOK, OMTR, PPG, SWY, WGO Comment!

• Thursday, July 16, 2009

• 07:08 AM Baxter International (BAX): Q2 EPS of $0.96 beats by $0.02. Revenue of $3.1B (-2.1%) in-line. (PR) Comment!
• 00:05 AM Notable earnings before Thursday's open: APH, BAX, BIIB, CY, FCS, GPC, HOG, JPM, MAR, MMR, MTG, NOK, NXY, PPG Comment!

• Monday, April 27, 2009

• 09:02 AM Premarket gainers on swine-flu speculation: NVAX +133%. SVA +63%. BCRX +58%. AVII +35%. VICL +32%. QDEL +26%. HGSI +19%. RAD +15%. CRXL +7%. BLUD +7%. HUM +6%. BAX +4%. GSK +4%. THC +4%. GILD +4%. 1 Comment

• Thursday, April 16, 2009

• 07:11 AM Baxter International (BAX): Q1 EPS of $0.83 beats by $0.02. Revenue of $2.82B (-1.8%) vs. $2.87B. (PR) Comment!
• 00:05 AM Notable earnings before Thursday's open: APH, BAX, CY, FCS, GCI, GPC, HOG, ITW, JPM, LUV, NOK, PH, SHW Comment!

• Sunday, March 1, 2009

• 05:09 AM Health-care giant Baxter International (BAX) might be just the cure for investors sick of anemic returns, writes Barron's Sandra Ward. The company delivered double-digit earnings growth last year and is expected to repeat the performance this year. 2 Comments

• Friday, January 23, 2009

• 10:39 AM After years of focusing on organic growth, Baxter (BAX) says it's considering outside deals: "It may be a more target-rich environment right now," CEO Robert Parkinson says on call. While not losing sight of margin expansion, he sees the chance to "be a bit more expansive in evaluating opportunities and perhaps bringing things in." Comment!

• Thursday, January 22, 2009

• 07:14 AM Baxter International (BAX): Q4 EPS of $0.91 beats by $0.02. Revenue of $3.13B (+4.1%) vs. $3.15B. (PR) Comment!
• 00:05 AM Notable earnings before Thursday's open: ABC, AUO, AVT, BAX, BBT, BEN, CIT, CMA, CY, EAT, ESI, EXC, FITB, HBAN, IGT, JNS, KEY, LMT, LUV, MTB, NITE, NOC, NOK, ORI, POT, SHW, STI, TCB, TSM, UNH, UNP, UST Comment!

• Thursday, October 16, 2008

• 07:21 AM Baxter (BAX): Q3 EPS of $0.88 beats by $0.06. Revenue of $3.15B (+14.6%) in-line. Cash flow from operations $1.9B up from $1.6B Y/Y. "The medically-necessary nature of our product offering, our diversified portfolio and global presence, and our financial strength and flexibility, provide us with a solid foundation in this uncertain global economy." [PR] Comment!
• 00:05 AM Notable earnings before Thursday's open: AMB, APH, BAX, BBT, BGG, BK, C, CAL, CIT, CY, DHR, FCS, HBAN, HOG, HSY, ITW, LUV, MER, NOK, NUE, PH, PNC, PPG, RS, SHW, SPWRA, SWKS, TXT, UTX, WERN, WTNY Comment!

• Thursday, July 17, 2008

• 08:28 AM Baxter (BAX): Q2 EPS of $0.85 beats by $0.03. Revenue of $3.2B vs. consensus $3.05B. Raises full-year EPS guidance to $3.28-3.32 from $3.18-3.24 vs. consensus $3.24. Shares -0.3%. [PR] Comment!
• 02:38 AM Notable earnings before Thursday's open: AOS, AMFI, BK, BAX, BBT, BLK, CHB, CIT, CCE, CMA, CAL, DHR, EDU, FCF, FFCH, GSBC, HOG, HNI, HOMB, HBAN, IGT, KNL, MMR, MEG, MEI, MTG, NAFC, NVS, ORB, PPG, PBKS, RS, SWY, SHW, SFNC, SOAP, SON, KO, UMPQ, UTX, VCP. Comment!